The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define the procedure for performing X-ray powder diffraction (XRD) analysis for the identification and characterization of the active pharmaceutical ingredient (API) in tablet formulations.
Click to read the full article.
To define the procedure for performing Fourier Transform Infrared (FTIR) spectroscopy analysis of excipients in tablet formulations, ensuring that the excipients used are accurately identified and meet the required quality standards.
Click to read the full article.
To define the procedure for using UV-Vis spectroscopy for dissolution analysis of tablets, ensuring that the dissolution rate and release profile of the active pharmaceutical ingredient (API) is accurately quantified.
Click to read the full article.
To define the procedure for identifying degradation products in tablet formulations, ensuring that degradation products are detected and quantified in accordance with regulatory standards.
Click to read the full article.
To define the procedure for performing assay testing using Gas Chromatography (GC) for determining the content of the active pharmaceutical ingredient (API) in tablet formulations.
Click to read the full article.
To define the procedure for robustness testing of analytical methods used for tablet testing, ensuring that the methods are reliable and consistent under varying conditions.
Click to read the full article.
To define the procedure for performing intermediate precision testing of analytical methods for tablets, ensuring that the method is consistent and reproducible under different operational conditions.
Click to read the full article.
To define the procedure for performing bulk density testing of granules used in tablet formulations, ensuring that the granules meet the required specifications for quality and consistency.
Click to read the full article.
To define the procedure for performing particle morphology analysis of granules and tablets in sustained release formulations, ensuring the uniformity and consistency of particle size, shape, and surface characteristics for optimal performance.
Click to read the full article.
To define the procedure for performing osmolarity testing for chewable and dispersible tablets, ensuring that the osmolarity of the formulation meets the required standards for oral administration.
Click to read the full article.